1. Home
  2. BG vs RVMD Comparison

BG vs RVMD Comparison

Compare BG & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bunge Limited

BG

Bunge Limited

HOLD

Current Price

$89.33

Market Cap

18.1B

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$80.52

Market Cap

15.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BG
RVMD
Founded
1818
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1B
15.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BG
RVMD
Price
$89.33
$80.52
Analyst Decision
Buy
Strong Buy
Analyst Count
6
17
Target Price
$114.00
$77.47
AVG Volume (30 Days)
1.3M
2.5M
Earning Date
02-04-2026
11-05-2025
Dividend Yield
3.06%
N/A
EPS Growth
9.16
N/A
EPS
8.69
N/A
Revenue
$60,109,000,000.00
N/A
Revenue This Year
$28.45
N/A
Revenue Next Year
$26.02
$714.50
P/E Ratio
$10.52
N/A
Revenue Growth
10.29
N/A
52 Week Low
$67.40
$29.17
52 Week High
$99.55
$81.49

Technical Indicators

Market Signals
Indicator
BG
RVMD
Relative Strength Index (RSI) 35.96 70.27
Support Level $90.11 $74.20
Resistance Level $93.93 $80.44
Average True Range (ATR) 2.27 2.77
MACD -0.44 -0.72
Stochastic Oscillator 7.38 88.05

Price Performance

Historical Comparison
BG
RVMD

About BG Bunge Limited

Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes and corn-based products in North and South America.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Share on Social Networks: